Janus Henderson Group’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Janus Henderson Group's ADPT Position: Q1 2026 in Review
Janus Henderson Group held its Adaptive Biotechnologies (ADPT) position steady in Q1 2026 at 46,900 shares worth $651K. The position accounts for ﹤0.01% of the portfolio, ranked #1889.
Janus Henderson Group first reported a position in ADPT in Q2 2019 and has held it in 19 quarters since. The position peaked at $12M in Q2 2019. 298 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.
- Janus Henderson Group held 46,900 shares of Adaptive Biotechnologies worth $651K as of Q1 2026.
- Janus Henderson Group left its Adaptive Biotechnologies share count unchanged in Q1 2026.
- Adaptive Biotechnologies made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #1889 holding.
- Janus Henderson Group first reported a position in Adaptive Biotechnologies in Q2 2019 and has held it in 19 quarters since.
- Janus Henderson Group's Adaptive Biotechnologies position peaked at $12M in Q2 2019.
- 298 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.
Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.